Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
Location
601 Brickell Key Drive, Suite 1000, Miami, FL
Fiscal year end
December 31
Former names
Summit Therapeutics plc (to 9/17/2020), Summit Corp plc (to 1/30/2015)
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 482 % -34.4%
Debt-to-equity 62.2 % -66.7%
Return On Equity -104 % +79.1%
Return On Assets -64.3 % +63%
Operating Margin -268K % -6725%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 737M shares +5.22%
Common Stock, Shares, Outstanding 737M shares +5.62%
Entity Public Float 108M USD +322%
Common Stock, Value, Issued 7.37M USD +5.63%
Weighted Average Number of Shares Outstanding, Basic 727M shares +4.14%
Weighted Average Number of Shares Outstanding, Diluted 727M shares +4.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 80.5M USD +94.7%
General and Administrative Expense 57.7M USD +120%
Operating Income (Loss) -197M USD +66.9%
Nonoperating Income (Expense) -85K USD +97.8%
Net Income (Loss) Attributable to Parent -197M USD +67.1%
Earnings Per Share, Basic 0.26 USD/shares -167%
Earnings Per Share, Diluted 0.26 USD/shares -167%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.8M USD +294%
Cash, Cash Equivalents, and Short-term Investments 186M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 181K USD -62.8%
Assets, Current 490M USD +139%
Property, Plant and Equipment, Net 265K USD +15.7%
Operating Lease, Right-of-Use Asset 7.98M USD +24.6%
Goodwill 1.99M USD +9.76%
Other Assets, Noncurrent 1.86M USD -57%
Assets 503M USD +130%
Accounts Payable, Current 3.25M USD -1.87%
Employee-related Liabilities, Current 7.96M USD +127%
Accrued Liabilities, Current 18.5M USD +406%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 59M USD -48.1%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 4.21M USD +8.46%
Other Liabilities, Noncurrent 1.72M USD +16.3%
Liabilities 64.9M USD -45.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.31M USD +0.65%
Retained Earnings (Accumulated Deficit) -1.15B USD -20.6%
Stockholders' Equity Attributable to Parent 438M USD +341%
Liabilities and Equity 503M USD +130%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.1M USD -129%
Net Cash Provided by (Used in) Financing Activities 485K USD -99.4%
Net Cash Provided by (Used in) Investing Activities 19.9M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 737M shares +5.62%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.81M USD +98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 94.1M USD +296%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.5M USD +14.9%
Deferred Tax Assets, Valuation Allowance 84.8M USD +32.4%
Deferred Tax Assets, Gross 86M USD +32.5%
Operating Lease, Liability 6.1M USD +37%
Depreciation 27K USD -70%
Payments to Acquire Property, Plant, and Equipment 4K USD -92.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -197M USD +67.1%
Lessee, Operating Lease, Liability, to be Paid 6.59M USD +34.7%
Property, Plant and Equipment, Gross 1.25M USD -43.4%
Operating Lease, Liability, Current 3.79M USD +36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.89M USD +92.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.81M USD +90.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 490K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 893K USD -41.7%
Deferred Tax Assets, Operating Loss Carryforwards 59M USD +11.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 1.06M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 367K USD +23.6%
Additional Paid in Capital 1.59B USD +50.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 48.7M USD +508%
Interest Expense 12.6M USD +5378%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%